医学期刊的幽灵：代笔如何推销“HRT”。
The haunting of medical journals: how ghostwriting sold "HRT".
机构信息
Department of Physiology and Biophysics, Georgetown University Medical Center, Washington, D.C., USA.
出版信息
PLoS Med. 2010 Sep 7;7(9):e1000335. doi: 10.1371/journal.pmed.1000335.
Abstract
Adriane Fugh-Berman examines documents unsealed in recent litigation to investigate how pharmaceutical companies promoted hormone therapy drugs, including the use of medical writing companies to produce ghostwritten manuscripts and place them into medical journals.
摘要
阿德里安·福格-伯曼审查了最近诉讼中解封的文件，以调查制药公司如何推广激素治疗药物，包括利用医疗写作公司撰写虚假论文并将其发表在医学期刊上。
相似文献
1
The haunting of medical journals: how ghostwriting sold "HRT".医学期刊的幽灵：代笔如何推销“HRT”。
PLoS Med. 2010 Sep 7;7(9):e1000335. doi: 10.1371/journal.pmed.1000335.
2
What should be done to tackle ghostwriting in the medical literature?应该采取什么措施来应对医学文献中的代笔问题？
PLoS Med. 2009 Feb 3;6(2):e23. doi: 10.1371/journal.pmed.1000023.
3
Profits and plagiarism: the case of medical ghostwriting.利润与剽窃：医学代写的案例。
Bioethics. 2010 Jul;24(6):267-72. doi: 10.1111/j.1467-8519.2008.00705.x. Epub 2009 Feb 16.
4
Ghost story: at medical journals, writers paid by industry play big role.鬼故事：在医学期刊领域，由行业资助的作者发挥着重要作用。
Wall St J (East Ed). 2005 Dec 13:A1, A8.
5
Hiring a professional medical writer: is it equivalent to ghostwriting?聘请专业医学撰稿人：是否等同于代写？
Biochem Med (Zagreb). 2014 Feb 15;24(1):19-24. doi: 10.11613/BM.2014.004. eCollection 2014.
6
Research misconduct policies of high impact biomedical journals.高影响力生物医学期刊的研究不端行为政策。
Account Res. 2006 Jul-Sep;13(3):247-58. doi: 10.1080/08989620600848199.
7
Standards for ethical publication.伦理出版标准。
Am J Otolaryngol. 2007 Jan-Feb;28(1):1-2. doi: 10.1016/j.amjoto.2006.11.002.
8
Ghostwriting: stringent disclosure policies take aim at authorship abuses.代笔问题：严格的披露政策旨在打击署名滥用行为。
Aesthet Surg J. 2010 Mar;30(2):265-6. doi: 10.1177/1090820X10370167.
9
Prevalence of ghostwriting spurs calls for transparency.代笔行为的盛行引发了对透明度的呼吁。
CMAJ. 2009 Oct 13;181(8):E161-2. doi: 10.1503/cmaj.109-3036. Epub 2009 Sep 21.
10
Editor's note: Industry support of articles published in Mayo Clinic Proceedings.编者按：梅奥诊所学报发表文章的行业支持情况。
Mayo Clin Proc. 2006 Jun;81(6):851-2. doi: 10.4065/81.6.851.
引用本文的文献
1
How big is the medical writing industry? Why it matters.医学写作行业规模有多大？为何它很重要。
Health Promot Int. 2025 Sep 3;40(5). doi: 10.1093/heapro/daaf146.
2
What did the scientific literature learn from internal company documents in the pharmaceutical industry? A scoping review.科学文献从制药行业的公司内部文件中学到了什么？一项范围综述。
Cochrane Evid Synth Methods. 2023 Apr 27;1(3):e12011. doi: 10.1002/cesm.12011. eCollection 2023 May.
3
Patient perspective: Is intensive screening of women at high risk of breast cancer evidence-based medicine or ?患者视角：对乳腺癌高危女性进行强化筛查是循证医学还是？ （原文最后“or”后面似乎内容不完整）
Womens Health (Lond). 2025 Jan-Dec;21:17455057241307089. doi: 10.1177/17455057241307089.
4
Insights of Healthcare Professionals into Medical Writing Support at a Tertiary Care Hospital in Saudi Arabia.沙特阿拉伯一家三级护理医院的医疗保健专业人员对医学写作支持的见解。
Cureus. 2024 Apr 28;16(4):e59190. doi: 10.7759/cureus.59190. eCollection 2024 Apr.
5
Promoting opioids, a story about how to influence medical science and opinions.推广阿片类药物，一个关于如何影响医学科学和观点的故事。
Front Med (Lausanne). 2024 Apr 26;11:1327939. doi: 10.3389/fmed.2024.1327939. eCollection 2024.
6
How the Suboxone Education Programme presented as a solution to risks in the Canadian opioid crisis: a critical discourse analysis.《Suboxone 教育计划如何被呈现为解决加拿大阿片类药物危机中的风险的一种方案：批判性话语分析》。
BMJ Open. 2022 Jul 12;12(7):e059561. doi: 10.1136/bmjopen-2021-059561.
7
Policing the promotion of prescription medicines - the new Medicines Australia Code of Conduct.规范处方药促销行为——澳大利亚药品行业新行为准则
Aust Prescr. 2021 Feb;44(1):4-5. doi: 10.18773/austprescr.2020.082. Epub 2021 Feb 1.
8
"I'm going to stay young": Belief in anti-aging efficacy of menopausal hormone therapy drives prolonged use despite medical risks.“我要保持年轻”：尽管存在医学风险，但对绝经激素治疗抗衰老功效的信念促使其长期使用。
PLoS One. 2020 May 29;15(5):e0233703. doi: 10.1371/journal.pone.0233703. eCollection 2020.
9
Industry sponsorship and research outcome.行业赞助与研究成果。
Cochrane Database Syst Rev. 2017 Feb 16;2(2):MR000033. doi: 10.1002/14651858.MR000033.pub3.
10
Sources of information influencing the state-of-the-science gap in hormone replacement therapy usage.影响激素替代疗法使用方面科学现状差距的信息来源。
PLoS One. 2017 Feb 3;12(2):e0171189. doi: 10.1371/journal.pone.0171189. eCollection 2017.
本文引用的文献
1
Ethical considerations of publication planning in the pharmaceutical industry.制药行业出版计划的伦理考量
Open Med. 2008;2(4):e121-4. Epub 2008 Dec 23.
2
Of sophists and spin-doctors: industry-sponsored ghostwriting and the crisis of academic medicine.论诡辩家和舆论导向专家：医药行业赞助的代笔行为与学术医学危机
Mens Sana Monogr. 2010 Jan;8(1):129-45. doi: 10.4103/0973-1229.58824.
3
Attitudes of obstetrician-gynecologists toward the evidence from the Women's Health Initiative hormone therapy trials remain generally skeptical.妇产科医生对妇女健康倡议激素治疗试验证据的态度总体上仍然持怀疑态度。
Menopause. 2009 May-Jun;16(3):500-8. doi: 10.1097/gme.0b013e31818fc36e.
4
The Neurontin legacy--marketing through misinformation and manipulation.加巴喷丁的遗留问题——通过错误信息和操纵手段进行营销。
N Engl J Med. 2009 Jan 8;360(2):103-6. doi: 10.1056/NEJMp0808659.
5
Off-label promotion, on-target sales.未标靶推广，目标明确销售。
PLoS Med. 2008 Oct 28;5(10):e210. doi: 10.1371/journal.pmed.0050210.
6
Industry-sponsored ghostwriting in clinical trial reporting: a case study.临床试验报告中行业资助的代笔行为：一项案例研究。
Account Res. 2008 Jul-Sep;15(3):152-67. doi: 10.1080/08989620802194384.
7
Factors associated with obstetrician-gynecologists' response to the Women's Health Initiative trial of combined hormone therapy.与妇产科医生对女性健康倡议联合激素疗法试验的反应相关的因素。
Med Decis Making. 2008 May-Jun;28(3):411-8. doi: 10.1177/0272989X07312722. Epub 2008 May 13.
8
Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation.与罗非昔布相关出版物中的客座作者身份和代笔行为：以罗非昔布诉讼中的行业文件为例
JAMA. 2008 Apr 16;299(15):1800-12. doi: 10.1001/jama.299.15.1800.
9
Ghost management: how much of the medical literature is shaped behind the scenes by the pharmaceutical industry?幽灵作者现象：医药行业在幕后对医学文献的影响究竟有多大？
PLoS Med. 2007 Sep;4(9):e286. doi: 10.1371/journal.pmed.0040286.
10
Gynecologists and estrogen: an affair of the heart.妇科医生与雌激素：心脏问题
Perspect Biol Med. 2006 Winter;49(1):115-30. doi: 10.1353/pbm.2006.0006.
Zotero 插件